Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Ivermectin mass drug administration to humans or livestock is a potential vector control tool for malaria elimination. Racemic ivermectin is composed of two components, namely a major component (> 80%; ivermectin B1a), which has an ethyl group at C-26, and a minor component (

Original publication

DOI

10.1186/s13071-024-06294-6

Type

Journal article

Journal

Parasit Vectors

Publication Date

15/05/2024

Volume

17

Keywords

Anopheles, Ivermectin B1a, Ivermectin B1b, Racemic ivermectin, Survival, Ivermectin, Animals, Anopheles, Insecticides, Humans, Mosquito Vectors, Female, Mosquito Control, Malaria